|
Jagsonpal Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1324.87 Cr.
|
P/BV
|
6.72
|
Book Value (Rs.)
|
29.53
|
|
52 Week High/Low (Rs.)
|
302/193
|
FV/ML
|
2/1
|
P/E(X)
|
23.93
|
|
Bookclosure
|
12/09/2025
|
EPS (Rs.)
|
8.29
|
Div Yield (%)
|
1.26
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 |
| Total Operating Revenues | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 |
| | | | | | |
| Other Income | 8.19 | 9.28 | 5.73 | 3.34 | 4.39 |
| Total Revenue | 276.91 | 217.98 | 242.45 | 229.43 | 192.34 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 18.34 | 22.10 | 31.21 | 40.42 | 38.63 |
| Purchase Of Stock-In Trade | 80.22 | 53.98 | 57.59 | 49.75 | 36.86 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -2.13 | 3.90 | 4.30 | 5.61 | 5.28 |
| Employee Benefit Expenses | 64.13 | 48.49 | 56.42 | 57.68 | 53.98 |
| Finance Costs | 0.96 | 0.81 | 0.41 | 0.29 | 1.09 |
| Provisions And Contingencies | 0.00 | 0.77 | 0.00 | 0.00 | 0.00 |
| Depreciation And Amortisation Expenses | 8.13 | 1.66 | 1.21 | 1.53 | 0.51 |
| Other Expenses | 57.08 | 56.40 | 53.04 | 46.84 | 34.11 |
| Total Expenses | 226.73 | 188.11 | 204.18 | 202.11 | 170.47 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 50.17 | 29.87 | 38.27 | 27.32 | 21.87 |
| | | | | | |
| Exceptional Items | 19.69 | 0.00 | -3.46 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 69.86 | 29.87 | 34.81 | 27.32 | 21.87 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 13.57 | 7.56 | 7.63 | 7.40 | 6.05 |
| Deferred Tax | 0.93 | -0.15 | 0.46 | 0.33 | -1.23 |
| Total Tax Expenses | 14.50 | 7.41 | 8.09 | 7.73 | 4.81 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | | |
| Profit/Loss From Continuing Operations | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | | |
| Profit/Loss For The Period | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.26 | 8.49 | 10.20 | 7.48 | 6.51 |
| Diluted EPS (Rs.) | 8.22 | 8.46 | 10.20 | 7.48 | 6.51 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 13.23 | 13.10 | 0.00 | 10.48 | 2.62 |
| Equity Dividend Rate (%) | 125.00 | 100.00 | 100.00 | 80.00 | 20.00 |
